Categories Earnings, Health Care

Earnings Summary: Charles River Laboratories reports Q2 2023 results

Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the second quarter of 2023.

  • For the quarter, the company reported revenues of $1.06 billion, up 8.9% from $973.1 million recorded in the prior-year quarter
  • Net income attributable to common shareholders was $97.0 million in Q2, compared to $109.3 million for the same period in 2022
  • On a per-share basis, Q2 unadjusted earnings decreased 11.3% year-over-year to $1.89 from $2.13 last year
  • Adjusted profit was $138.3 million in the June quarter, which is down 2.5% from the prior-year period
  • Earnings per share, on an adjusted basis, decreased 2.9% year-over-year to $2.69 during the three-month period
  • The management expects revenues to increase in the range of 2.5% to 4.5% in fiscal 2023

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

NKE Earnings: Here’s everything you need to know about Nike’s Q1 report

Nike, Inc. (NYSE: NKE) on Thursday reported results for the first three months of fiscal 2024, reporting a modest rise in revenues. The sneaker giant reported net income of $1.45

Key takeaways from Accenture’s (ACN) Q4 2023 earnings report

Shares of Accenture plc (NYSE: ACN) were down 4% on Thursday after the company delivered mixed results for the fourth quarter of 2023 and provided full-year guidance that came below

CarMax (KMX) Q2 2024 Earnings: Key financials and quarterly highlights

CarMax, Inc. (NYSE: KMX) reported second quarter 2024 earnings results today. Net revenues were $7.1 billion, down 13.1% compared to the same period a year ago. Net earnings declined 5.8%

Add Comment
Viewing Highlight